Those on multiple serotonergic agents or with hepatic impairment should have dosing reviewed by their prescriber
Funding information National Institutes of Health, Grant/Award Numbers: R01 DK119169, DK1191305830 DATA AVAILABILITY STATEMENT The data that support the findings of this study are available from the corresponding author upon reasonable request
And because Paulas Choice came up with a formula that should be exactly what the others are not: effective, but also gentle and soothing
Zelniker TA, Wiviott SD, Raz I, Im K, Goodrich EL, Bonaca MP, Mosenzon O, Kato ET, Cahn A, Furtado RHM, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Sabatine MS (2019) SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials